BLMH

bleomycin hydrolase

Summary

Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]

Known Variants29 total

rsidPosition (GRCh37)AllelesClassClinVar
rs105056517:28,576,076T/Cmissense variantbenign
rs14822597117:28,576,085C/T—uncertain significance
rs11619428917:28,576,106C/T—uncertain significance
rs18959889017:28,578,014A/Gupstream gene variant—
rs14889419817:28,579,420A/Gdownstream gene variant—
rs7507661517:28,580,395C/Tdownstream gene variant—
rs18112694417:28,584,612C/Tintron variant—
rs379480617:28,586,903T/Gintron variant—
rs14653450017:28,587,761C/Tintron variant—
rs212978517:28,590,530T/Cintron variant—
rs13788171917:28,598,294C/Astop gained—
rs250963764617:28,598,348G/C—uncertain significance
rs36808846917:28,599,609T/C—uncertain significance
rs75451331917:28,599,613A/C—uncertain significance
rs37231078517:28,599,778G/A—uncertain significance
rs75842840317:28,599,805A/G—uncertain significance
rs250963882617:28,599,875T/C—uncertain significance
rs54299669917:28,599,877T/C—uncertain significance
rs86835218917:28,601,172G/A—uncertain significance
rs18553358017:28,606,498G/Aintron variant—
rs14023342917:28,608,636A/Gintron variant—
rs250964551117:28,612,456C/T—uncertain significance
rs135657567417:28,614,937G/C—uncertain significance
rs76072124517:28,614,940C/T—likely benign
rs75577663917:28,616,497C/T—uncertain significance
rs14354476417:28,618,350T/C—likely benign
rs159767012717:28,618,413G/A—uncertain significance
rs75507778417:28,618,497T/A—uncertain significance
rs15014429017:28,618,517G/A—uncertain significance

Gene information from NCBI Gene. Variant classifications from ClinVar.